Treatment of Y-79 human retinoblastoma cell line with CA was able to inhibit the expression levels of MELK and FoxM1 while also reducing the transcriptional activity of FoxM1 to a baseline level (Table 2) [125]. Here, FOXM1 is linked to retinoblastoma.